Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta Cited by

Acta Medica > Archive > 2021, Vol. 64 > Issue 3 > p. 187 > Cited by

Acta Med. 2021, 64: 187-192

https://doi.org/10.14712/18059694.2021.32

Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta

Štěpán Kutílek^a,b,c, Ivana Plášilová^a,c, Sylva Skálová^a, Milan Bayer^a,d, Erika Ondrušová^a

^aDepartment of Pediatrics, Faculty of Medicine and Faculty Hospital in Hradec Králové, Charles University, Hradec Králové, Czech Republic
^bDepartment of Pediatrics, Klatovy Hospital, Klatovy, Czech Republic
^cDepartment of Pediatrics, Pardubice Hospital, Pardubice, Czech Republic
^dDepartment of Pediatrics, 3rd Faculty of Medicine and University Hospital Královské Vinohrady, Charles University in Prague, Czech Republic

Received December 13, 2019
Accepted August 12, 2021

Crossref Cited-by Linking

Tichá \u013dubica, Podracká \u013dudmila: Management of osteoporosis in children. Clin Osteol 2025, 30, 203. <https://doi.org/10.36290/clo.2025.033>
Multiple drugs. Reactions Weekly 2022, 1891, 207. <https://doi.org/10.1007/s40278-022-09459-3>

Acta MedicaJournal of Faculty of Medicine in Hradec Králové

Acta Med. 2021, 64: 187-192

Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta

Crossref Cited-by Linking

Acta Medica
Journal of Faculty of Medicine in Hradec Králové